---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-278669"
form_type: "8-K"
ticker: "SBC"
cik: "0001930313"
company_name: "SBC Medical Group Holdings Inc"
filed_at: "2025-11-13T23:59:59+00:00"
generated_at: "2026-05-16T20:37:36.094732+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SBC Medical Group to acquire Waqoo via tender offer; CEO selling 26.6% stake at discounted price

## Summary
- SBCMG to tender for up to 575,000 Waqoo shares at JPY 1,900 each; period Nov 14–Dec 12, 2025.
- CEO Yoshiyuki Aikawa to sell his 989,802 shares (26.58%) off-market at JPY 1,445 per share, a discount to tender price.
- Post-transaction, Waqoo will become a consolidated subsidiary of SBC Medical Group.
- SBCMG currently holds 9.49% of Waqoo; combined with CEO's stake, effective control exceeds 36%.
- Strategic rationale: integrate Waqoo's R&D in AGA, orthopedics, skincare, and regenerative medicine.

## SEC filing metadata
- accession: 0001193125-25-278669
- form_type: 8-K
- ticker: SBC
- cik: 0001930313
- company_name: SBC Medical Group Holdings Inc
- filed_at: 2025-11-13T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1930313/000119312525278669/0001193125-25-278669-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1930313/000119312525278669/sbc-20251113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-278669
- JSON: https://secwatch.observer/filing/0001193125-25-278669.json
- Plain text: https://secwatch.observer/filing/0001193125-25-278669.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.